SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-18-178450
Filing Date
2018-05-30
Accepted
2018-05-30 16:10:10
Documents
12
Effectiveness Date
2018-05-30

Document Format Files

Seq Description Document Type Size
1 F-3ASR d570266df3asr.htm F-3ASR 521730
2 EX-4.4 d570266dex44.htm EX-4.4 294777
3 EX-5.1(A) d570266dex51a.htm EX-5.1(A) 27082
4 EX-5.1(B) d570266dex51b.htm EX-5.1(B) 22994
5 EX-8.1 d570266dex81.htm EX-8.1 20760
6 EX-12.1 d570266dex121.htm EX-12.1 22866
7 EX-23.1 d570266dex231.htm EX-23.1 2821
8 EX-25.1 d570266dex251.htm EX-25.1 137585
9 GRAPHIC g570266g66e35.jpg GRAPHIC 9807
10 GRAPHIC g570266g81r14.jpg GRAPHIC 33472
11 GRAPHIC g570266g96b35.jpg GRAPHIC 9120
12 GRAPHIC g570266snap1.jpg GRAPHIC 6534
  Complete submission text file 0001193125-18-178450.txt   1122552
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-3ASR | Act: 33 | File No.: 333-225284 | Film No.: 18868195
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1